Wuxi Pharmaceutical Kangde New Drug Development Co., Ltd. is a Chinese investment holding company which mainly provides new drug research and development, production and supporting services as well as related technology platform services. The company mainly discovers, develops and produces small molecular drugs, cell therapy and gene therapy, as well as providing medical device testing services. The company operates through four business units, including China Laboratory Services, contract production Organization / contract R & D and production Organization Services (CMO/CDMO Services), US Laboratory Services and Clinical Research Services.
CEO： Ge Li
Market： Hong Kong motherboard